Alison Green Selected Research

14-3-3 Proteins (14-3-3 Protein)

12/2019	Diagnostic value of surrogate CSF biomarkers for Creutzfeldt-Jakob disease in the era of RT-QuIC.
5/2016	Validation of 14-3-3 Protein as a Marker in Sporadic Creutzfeldt-Jakob Disease Diagnostic.
10/2012	Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years.
10/2009	Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies.
5/2009	The role of cerebrospinal fluid proteins as early diagnostic markers for sporadic Creutzfeldt-Jakob disease.
8/2004	Advances in diagnosing Creutzfeldt-Jakob disease with MRI and CSF 14-3-3 protein analysis.
5/2002	Biochemical investigations in patients with dementia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alison Green Research Topics

Disease

10	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 01/2021 - 07/2002
8	Sporadic Creutzfeldt-Jakob Disease 01/2021 - 05/2002
5	Dementia (Dementias) 12/2021 - 05/2002
5	Prion Diseases (Transmissible Spongiform Encephalopathies) 01/2017 - 11/2004
3	Parkinson Disease (Parkinson's Disease) 12/2021 - 01/2019
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 01/2019
3	Disease Progression 01/2019 - 05/2002
3	Stroke (Strokes) 01/2019 - 01/2011
3	Acquired CJD 01/2017 - 11/2004
2	Fatal Familial Insomnia 01/2017 - 10/2009
2	Infections 10/2011 - 01/2008
1	COVID-19 02/2022
1	Synucleinopathies 06/2019
1	Proteostasis Deficiencies 01/2019
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 06/2018
1	Hemolysis 05/2016
1	Relapsing-Remitting Multiple Sclerosis 03/2012
1	Multiple Sclerosis 03/2012
1	Ischemic Stroke 01/2012
1	Transient Ischemic Attack 01/2012
1	Bronchial Spasm 10/2011
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2011
1	Acquired Immunodeficiency Syndrome (AIDS) 10/2008
1	Scrapie 01/2008
1	Gliosis 09/2006
1	Alzheimer Disease (Alzheimer's Disease) 05/2002

Drug/Important Bio-Agent (IBA)

13	Biomarkers (Surrogate Marker)IBA 01/2021 - 05/2002
8	PrionsIBA 12/2019 - 01/2008
7	14-3-3 Proteins (14-3-3 Protein)IBA 12/2019 - 05/2002
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2006
4	Prion ProteinsIBA 01/2021 - 12/2007
3	Codon (Codons)IBA 10/2009 - 07/2007
2	SynucleinsIBA 06/2019 - 01/2019
2	tau Proteins (tau Protein)IBA 10/2009 - 05/2002
2	Phosphopyruvate Hydratase (Enolase)IBA 10/2009 - 09/2006
2	Cerebrospinal Fluid ProteinsIBA 05/2009 - 07/2002
1	COVID-19 VaccinesIBA 02/2022
1	Glucosylceramidase (Glucocerebrosidase)IBA 12/2021
1	EnzymesIBA 12/2019
1	ImmunosorbentsIBA 12/2019
1	Indicators and Reagents (Reagents)IBA 12/2019
1	Phosphotransferases (Kinase)IBA 06/2019
1	Leucine (L-Leucine)FDA Link 06/2019
1	Hormones (Hormone)IBA 01/2019
1	Retinaldehyde (Retinal)IBA 01/2019
1	alpha-SynucleinIBA 10/2013
1	Amyloid (Amyloid Fibrils)IBA 10/2012
1	Alemtuzumab (Campath)FDA Link 03/2012
1	Monoclonal AntibodiesIBA 03/2012
1	InterferonsIBA 03/2012
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2012
1	Interleukin-6 (Interleukin 6)IBA 01/2012
1	Pentamidine (NebuPent)FDA LinkGeneric 10/2011
1	pro-brain natriuretic peptide (1-76)IBA 01/2011
1	Dendrimers (Dendrons)IBA 10/2008
1	Poly(amidoamine)IBA 10/2008
1	alpha 1-Antichymotrypsin (alpha 1 Antichymotrypsin)IBA 01/2008
1	Uric Acid (Urate)IBA 11/2004
1	ApolipoproteinsIBA 07/2002
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 05/2002
1	Peptides (Polypeptides)IBA 05/2002
1	Amyloid beta-PeptidesIBA 05/2002

Therapy/Procedure

2	Therapeutics 01/2019 - 10/2011
1	Transplantation 01/2019